Cargando…
Anti-Inflammatory Effects of the Novel PIM Kinase Inhibitor KMU-470 in RAW 264.7 Cells through the TLR4-NF-κB-NLRP3 Pathway
PIM kinases, a small family of serine/threonine kinases, are important intermediates in the cytokine signaling pathway of inflammatory disease. In this study, we investigated whether the novel PIM kinase inhibitor KMU-470, a derivative of indolin-2-one, inhibits lipopolysaccharide (LPS)-induced infl...
Autores principales: | Baek, Hye Suk, Min, Hyeon Ji, Hong, Victor Sukbong, Kwon, Taeg Kyu, Park, Jong Wook, Lee, Jinho, Kim, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403980/ https://www.ncbi.nlm.nih.gov/pubmed/32698512 http://dx.doi.org/10.3390/ijms21145138 |
Ejemplares similares
-
KMU-1170, a Novel Multi-Protein Kinase Inhibitor, Suppresses Inflammatory Signal Transduction in THP-1 Cells and Human Osteoarthritic Fibroblast-Like Synoviocytes by Suppressing Activation of NF-κB and NLRP3 Inflammasome Signaling Pathway
por: Baek, Hye Suk, et al.
Publicado: (2021) -
Identification of KMU-3, a Novel Derivative of Gallic Acid, as an Inhibitor of Adipogenesis
por: Park, Yu-Kyoung, et al.
Publicado: (2014) -
Helixor-M Suppresses Immunostimulatory Activity through TLR4-Dependent NF-κB Pathway in RAW 264.7 Cells
por: Park, Doil, et al.
Publicado: (2023) -
The uptake of tocopherols by RAW 264.7 macrophages
por: Gao, Rong, et al.
Publicado: (2002) -
Performance Management in KMU
por: Grünbichler, Rudolf, et al.
Publicado: (2020)